Effect of chemotherapy on quality of life in patients with non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-014-2148-9.pdf
Reference116 articles.
1. Aaronson NK (1992) Assessing the quality of life of patients in cancer clinical trials. Common problems and common sense solutions. Eur J Cancer 28A:1304–1307
2. Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ (1997) Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small cell lung cancer. J Clin Oncol 15:744–749
3. Akerly W, Glantz M, Choy H et al (1998) Phase II trial of weekly paclitaxel in advanced non-small cell lung cancer. J Clin Oncol 16:153–158
4. Anderson H, Hopwood P, Stephens RJ et al (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer—a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Br J Cancer 83:447–453
5. Baka S, Ashcroft L, Anderson M et al (2005) Randomized phase III study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status <70) and advanced non-small-cell lung cancer. J Clin Oncol 23:2136–2144
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer-Related Malnutrition and the Role of Parenteral Nutrition in Cancer; A Narrative Review;Nutrition and Cancer;2024-07-22
2. Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06–2018 study);Lung Cancer;2024-07
3. Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study);Supportive Care in Cancer;2024-04-27
4. Timely identification of malnutrition and cachexia as a first step towards better clinical outcome in cancer patients: a mini review;Pharmacy & Pharmacology International Journal;2023-11-14
5. Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3